The role of Toll -like receptor 4 for peritonitis and peritoneal fibrosis in CAPD patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20151113002

Enrollment

Registered

2015-11-13

Start date

2015-10-27

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

end&#45

Interventions

peritonitis and peritoneal fibrosis in CAPD patients

Other

peritonitis and peritoneal fibrosis

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: peritonitis or peritoneal fibrosis in CAPD patients whose peritoneal dialysis duration is more than 3 months

Exclusion criteria

Exclusion criteria: 1.CAPD patients whose peritoneal dialysis duration less than 3 months 2.CAPD patients who suffer from primary peritonitis 3.CAPD patients who suffer from peritonitis secondary to abdominal trauma or intra-abdominal infection etc.

Design outcomes

Primary

Measure	Time frame
TLR4mRNA 2 years R-TPCR western-blot	—

Secondary

Measure	Time frame
IL-6 IL-8 TGFÎ²1collagenI 2 years Elisa	—

Countries

China

Contacts

Public Contactchen xue

sichuan university

1280418136@qq.com13568952856

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

The role of Toll &#45;like receptor 4 for peritonitis and peritoneal fibrosis in CAPD patients